Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

No Special Price for Novel Pack: NPPA Panel Turns Down Sun Pharma's Amoxicillin-Clavulanic Formulation

Farhat Nasim25 July 2025 5:24 PM IST

New Delhi: In a regulatory pushback against what it deemed an ineligible pricing request, the Multi-Disciplinary Committee (MDC) of the National...

NPPA Panel Rejects Dr Reddy's Omez ODT Plea For Seperate Price, Finds No Therapeutic Edge

Farhat Nasim24 July 2025 6:54 PM IST

New Delhi: In a decisive move against what it viewed as an unjustified price escalation, the Multi-Disciplinary Committee (MDC) under India's drug...

Delhi HC Bars Zydus From Launching Cancer Drug Nivolumab Biosimilar Till 2026

Farhat Nasim23 July 2025 4:45 PM IST

New Delhi: In a major setback to Zydus Lifesciences, the Delhi High Court has restrained the company from launching its proposed biosimilar of the...

1-Year Ban for Fake Docs, Mandatory Disposal of Near-Expiry Stock: CDSCO Revises Pharma Export Rules

Farhat Nasim21 July 2025 11:51 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a revised guidance document detailing the procedure for the issuance of...

Substandard Deworming Medicines Detected

State Drug Alert: 130 Batches Found Not of Standard Quality in June; No Data Received from Delhi, Gujarat, UP

Farhat Nasim20 July 2025 5:36 PM IST

New Delhi: Reflecting ongoing concerns around drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation...

CDSCO Declares 74 Medicines, APIs and Devices Samples Not of Standard Quality in December

CDSCO Flags 55 Substandard, 4 Spurious Drugs in June Batch Alert, Full List Inside

Farhat Nasim19 July 2025 3:00 PM IST

New Delhi: In its latest regulatory update for June 2025, the Central Drugs Standard Control Organisation (CDSCO) has flagged a total of 55 drug...

2 PMJAY empanelled hospitals suspended, show cause notices issued to two more

Drug Inspector Suspended Over Irregularities in Inspections

Farhat Nasim17 July 2025 9:39 PM IST

The suspension was announced "with immediate effect" after an internal probe found "serious irregularities" in narcotics inspections.

"2800 Grade Pay Wale": Drug Inspector in Hooter Car Grabs SHO, Video Goes Viral

Farhat Nasim17 July 2025 9:37 PM IST

Amethi: A dramatic scene unfolded on the Munshiganj-Amethi road on Wednesday evening after a car fitted with a hooter and bearing a "Government of...

Centre Extends DCGI Rajeev Singh Raghuvanshis Tenure Again

No Eligible Successor: Centre Clarifies DCGI's Contractual Reappointment

Farhat Nasim15 July 2025 9:30 PM IST

New Delhi: Amid an ongoing legal challenge in the Madurai High Court, the Central government has clarified that its decision to reappoint Dr Rajeev...

Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority Nod

Do Not Issue Licenses Without New Drug Permission from DCGI, Govt Panel Tells States

Farhat Nasim14 July 2025 11:28 PM IST

New Delhi: In a move to reinforce coordination between central and state drug regulatory bodies, the Drugs Consultative Committee (DCC) has called on...

After Son’s Death, Father’s Legal Battle Leads to Vasai Hospital Licence Cancellation

4 Pharma Firms Lose Licenses Over Pregabalin, Tapentadol Misuse

Farhat Nasim13 July 2025 10:00 AM IST

Jammu: Cracking down on the illegal sale of habit-forming pharmaceutical drugs, the Jammu and Kashmir Drugs Control Department has cancelled the...

After Cough Syrup Deaths, IPC Issues Toolkit to Curb DEG, EG Contamination in Liquid Formulations

Unreadable Expiry Dates, Generic Mix-Ups: Govt Panel Proposes Forming Sub-Committee on Medicine Labelling

Farhat Nasim12 July 2025 8:25 PM IST

New Delhi: In a move responding directly to widespread consumer grievances, the Drugs Consultative Committee (DCC), a statutory body under the Central...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok